The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.125
Bid: 0.11
Ask: 0.14
Change: 0.00 (0.00%)
Spread: 0.03 (27.273%)
Open: 0.125
High: 0.125
Low: 0.125
Prev. Close: 0.125
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Jul 2017 11:10

RNS Number : 4378M
Deltex Medical Group PLC
28 July 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

DELTEX MEDICAL GROUP PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: MISSED DISCLOSURE DUE TO SHARES IN ISSUE CHANGE

3. Details of person subject to the notification obligationiv

Name

J O HAMBRO CAPITAL MANAGEMENT LIMITED

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

27 JULY 2017

6. Date on which issuer notified (DD/MM/YYYY):

28 JULY 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.72%

0.00%

9.72%

313,115,807

Position of previous notification (if

applicable)

10.68%

0.00%

10.68%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0059337583

30,419,696

9.72%

SUBTOTAL 8. A

30,419,696

9.72%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

-

The number and % of voting rights held

-

The date until which the voting rights will be held

-

11. Additional informationxvi

.

 

 

Place of completion

J O HAMBRO CAPITAL MANAGEMENT, LONDON

Date of completion

28 JULY 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEXPAELXEFF
Date   Source Headline
4th Apr 20127:00 amRNSIssue of Equity
29th Mar 20127:00 amRNSCardioQ-ODM in emergency abdominal surgery
26th Mar 20128:34 amRNSHolding(s) in Company
23rd Mar 20122:08 pmRNSHolding(s) in Company
21st Mar 20124:48 pmRNSIssue of Equity
16th Mar 201212:59 pmRNSIssue of Equity
14th Mar 20127:00 amRNSCardioQ Canadian Implementation Progress
7th Mar 20127:00 amRNSDeltex Medical awarded NHS Supply Chain tender
7th Mar 20127:00 amRNSResults Summary for the year ended 31 Dec 2011
5th Mar 20127:00 amRNSITAPP promotes intra-operative fluid monitoring
1st Mar 20128:29 amRNSHolding(s) in Company
22nd Feb 20127:00 amRNSDeltex Medical selected for US evaluation project
5th Jan 20127:00 amRNSPre-close update on the year ended 31 Dec 2011
21st Dec 20112:13 pmRNSCorrection - Issue of Equity
21st Dec 20117:00 amRNSBenefits of CardioQ-ODM in bladder surgery
14th Dec 20117:00 amRNSIssue of Equity
9th Dec 20119:00 amRNSNCEPOD supports NICE guidance on CardioQ-ODM
7th Dec 20114:32 pmRNSIssue of Equity
7th Dec 20114:01 pmRNSDirector/PDMR Shareholding
6th Dec 20117:00 amRNSNHS Innovation Review prioritises ODM
30th Nov 201112:13 pmRNSIssue of Equity
1st Nov 20118:22 amRNSDirector/PDMR Shareholding
28th Sep 20115:16 pmRNSGrant of Options
28th Sep 20115:06 pmRNSDirectors' Shareholdings / Issue of Equity
14th Sep 20117:00 amRNSInterim Results
18th Jul 20117:00 amRNSTrading Statement
17th Jun 201110:24 amRNSTotal Voting Rights - Correction
6th Jun 20115:46 pmRNSAdditional Listing
31st May 201112:18 pmRNSHolding(s) in Company
19th May 20112:35 pmRNSDirector/PDMR Shareholding
12th May 20117:00 amRNSNotification of Major Interest in Shares
11th May 20114:56 pmRNSNotification of Major Interest in Shares
28th Apr 201111:31 amRNSResult of AGM
28th Apr 201111:00 amRNSAGM Statement
19th Apr 20111:25 pmRNSIssue of Equity
19th Apr 20111:21 pmRNSDirectors' Shareholdings / Issue of Equity
19th Apr 201111:07 amRNSDirectors' Share Dealings
15th Apr 20113:28 pmRNSIssue of Equity
15th Apr 20113:04 pmRNSIssue of Equity
5th Apr 20117:00 amRNSAdditional Listing
30th Mar 20117:00 amRNSFinal NICE guidance recommends CardioQ-ODMT
22nd Mar 20117:00 amRNSHolding(s) in Company
11th Mar 20114:36 pmRNSHolding(s) in Company
10th Mar 20111:05 pmRNSIssue of Equity
1st Mar 20117:00 amRNSPreliminary Results Announcement
21st Feb 20117:00 amRNSAdditional Listing
13th Jan 20117:00 amRNSPre-close update on the year ended 31 Dec 2010
23rd Dec 201012:45 pmRNSDirectors Shareholdings
23rd Dec 201012:39 pmRNSGrant of Options
23rd Dec 201012:35 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.